A Proof-of-Concept Study of LAD328 in Adults With Hidradenitis Suppurativa
NCT07547813
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Hidradenitis Suppurativa
Interventions
DRUG:
LAD328
OTHER:
Placebo
Sponsor
Almirall, S.A.